AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Case Report | Open Access

Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China
Show Author Information

Abstract

We describe a unique case in which a patient was initially diagnosed with meningoencephalitis and then detected anti-myelin oligodendrocyte glycoprotein (MOG) antibody and demyelinating brain lesions. A 43-year-old Chinese man who complained of headache and fever, was diagnosed with meningoencephalitis after cerebrospinal fluid (CSF) analysis. One month after onset, brain imaging revealed multiple lesions in bilateral white matter, and the anti-MOG antibody was detected in his serum and CSF (titer is 1:32 and 1:10, respectively). After a 3-month glucocorticoid therapy, repeated brain imaging and serological analysis for anti-MOG antibodies showed significant improvement. Multiple intracranial demyelinating lesions secondary to meningoencephalitis may be accompanied by anti-MOG antibody positivity, which can be reversed by hormone therapy.

References

[1]

Narayan RN, Wang C, Sguigna P, et al. Atypical anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. Mult Scler Relat Disord. 2019;27: 30-33.

[2]

Nagabushana D, Shah R, Pendharkar H, et al. MOG antibody seropositive aseptic meningitis: a new clinical phenotype. J Neuroimmunol. 2019;333: 476960.

[3]

Suzuki T, Maekawa K, Matsuo K, et al. Aseptic meningitis as an initial manifestation of anti-myelin oligodendrocyte glycoprotein antibody-associated disease. Intern Med. 2019;58(22): 3319-3321.

[4]

Vibha D, Singh RK, Salunkhe M, et al. MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrum. Neurol Sci. 2021;42(1): 321-323.

[5]

Miller CJ, Bennett J, Lee M. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis with considerable white blood cell elevation in cerebrospinal fluid. Mult Scler Relat Disord. 2020;46: 102455.

[6]

Shi BX, Jiang W, He MW, et al. Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare. Mult Scler Relat Disord. 2020;41: 102013.

[7]

Leinert J, Neumaier-Probst E, Kutschke G, et al. MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy. Mult Scler Relat Disord. 2020;41: 102050.

[8]

Shen WB, Zhang YE, Zhou CG, et al. Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis. BMC Neurol. 2021;21(1): 10.

[9]

Perrin PJ, Lavi E, Rumbley CA, et al. Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice. Clin Immunol. 1999;91(1): 41-49.

[10]

Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12): 3128-3138.

[11]

Fujiki F, Tsuboi Y, Hori T, et al. Aseptic meningitis as initial presentation of acute disseminated encephalomyelitis. J Neurol Sci. 2008;272(1/2): 129-131.

[12]

Shintani S, Fumimura Y, Shiigai T. Acute disseminated encephalomyelitis following aseptic meningoencephalitis. Clin Neurol Neurosurg. 2001;103(3): 155-159.

[13]

Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3): 276-283.

[14]

Chen JJ, Flanagan EP, Bhatti MT, et al. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020;95(2): e111-e120.

[15]

Tanaka M, Tanaka K. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. J Neuroimmunol. 2014;270(1/2): 98-99.

[16]

Waters P, Woodhall M, O'Connor KC, et al. MOG cell-based assay detects nonMS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015;2(3): e89.

[17]

Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2): 177-189.

[18]

Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2): 162-173.

[19]

Ducloyer JB, Caignard A, Aidaoui R, et al. MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis. Br J Ophthalmol. 2020;104(6): 842-845.

[20]

Netravathi M, Holla VV, Nalini A, et al. Myelin oligodendrocyte glycoproteinantibody-associated disorder: a new inflammatory CNS demyelinating disorder. J Neurol. 2021;268(4): 1419-1433.

[21]

Mariotto S, Ferrari S, Monaco S, et al. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. J Neurol. 2017;264(12): 2420-2430.

[22]

Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 2018;90(21): e1858-e1869.

[23]

Ramanathan S, Mohammad S, Tantsis E, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018;89(2): 127-137.

[24]

Akaishi T, Sato DK, Takahashi T, et al. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein. Neurochem Int. 2019;130: 104319.

[25]

Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody disease. J Neurol. 2019;266(5): 1280-1286.

[26]

Cobo-Calvo Á, Ruiz A, D'Indy H, et al. MOG antibody-related disorders: common features and uncommon presentations. J Neurol. 2017;264(9): 1945-1955.

Journal of Neurorestoratology
Article number: 100007
Cite this article:
Li Y, Liu X, Wang J, et al. Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder. Journal of Neurorestoratology, 2022, 10(3): 100007. https://doi.org/10.1016/j.jnrt.2022.100007

626

Views

0

Crossref

0

Web of Science

0

Scopus

Altmetrics

Received: 02 March 2022
Revised: 27 May 2022
Accepted: 03 June 2022
Published: 27 June 2022
© 2022 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Return